Lanean...
Nanoparticle drug delivery can reduce the hepatotoxicity of therapeutic cargo
Hepatotoxicity is a key concern in the clinical translation of nanotherapeutics because preclinical studies have consistently shown that nanotherapeutics accumulate extensively in the liver. However, clinical stage nanotherapeutics have not shown increased hepatotoxicity. Factors that can contribute...
Gorde:
| Argitaratua izan da: | Small |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7873714/ https://ncbi.nlm.nih.gov/pubmed/31972070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/smll.201906360 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|